Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

[C-peptide structure, functions and molecular mechanisms of action].

Shpakov AO, Granstrem AO.

Tsitologiia. 2013;55(1):16-27. Review. Russian.

PMID:
23662575
2.

[NEW ACHIEVEMENTS IN THE STUDY OF THE MECHANISMS AND TARGETS OF ACTION OF PROINSULIN C-PEPTIDE].

Shpakov AO.

Tsitologiia. 2015;57(6):405-14. Review. Russian.

PMID:
26495706
3.

C-peptide and diabetic neuropathy.

Sima AA.

Expert Opin Investig Drugs. 2003 Sep;12(9):1471-88. Review.

PMID:
12943492
4.

The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.

van der Westhuizen ET, Werry TD, Sexton PM, Summers RJ.

Mol Pharmacol. 2007 Jun;71(6):1618-29. Epub 2007 Mar 9.

5.

[C-peptide physiological effects].

Shpakov AO, Granstrem OK.

Ross Fiziol Zh Im I M Sechenova. 2013 Feb;99(2):196-211. Review. Russian.

PMID:
23650733
6.

Type 1 diabetic neuropathy and C-peptide.

Sima AA, Zhang W, Grunberger G.

Exp Diabesity Res. 2004 Jan-Mar;5(1):65-77. Review.

7.

Molecular effects of proinsulin C-peptide.

Johansson J, Ekberg K, Shafqat J, Henriksson M, Chibalin A, Wahren J, Jörnvall H.

Biochem Biophys Res Commun. 2002 Aug 2;295(5):1035-40. Review.

PMID:
12135597
8.

Molecular and cellular effects of C-peptide--new perspectives on an old peptide.

Wahren J, Shafqat J, Johansson J, Chibalin A, Ekberg K, Jörnvall H.

Exp Diabesity Res. 2004 Jan-Mar;5(1):15-23. Review.

9.

C-peptide: a new potential in the treatment of diabetic nephropathy.

Wahren J, Ekberg K, Samnegård B, Johansson BL.

Curr Diab Rep. 2001 Dec;1(3):261-6. Review.

PMID:
12643208
10.

C-Peptide effects on renal physiology and diabetes.

Rebsomen L, Khammar A, Raccah D, Tsimaratos M.

Exp Diabetes Res. 2008;2008:281536. doi: 10.1155/2008/281536. Review.

11.

C-peptide, Na+,K(+)-ATPase, and diabetes.

Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M.

Exp Diabesity Res. 2004 Jan-Mar;5(1):37-50. Review.

12.

[Proinsulin C-peptide -- the bioactive peptide with a huge promise].

Walenciak Ł, Fendler W, Młynarski W.

Pediatr Endocrinol Diabetes Metab. 2007;13(2):95-8. Review. Polish.

PMID:
17880815
13.

Effects of C-peptide on microvascular blood flow and blood hemorheology.

Forst T, Kunt T.

Exp Diabesity Res. 2004 Jan-Mar;5(1):51-64. Review.

14.

C-peptide makes a comeback.

Wahren J, Jörnvall H.

Diabetes Metab Res Rev. 2003 Sep-Oct;19(5):345-7. Review.

PMID:
12951641
15.

Molecular basis for the insulinomimetic effects of C-peptide.

Grunberger G, Qiang X, Li Z, Mathews ST, Sbrissa D, Shisheva A, Sima AA.

Diabetologia. 2001 Oct;44(10):1247-57.

PMID:
11692173
16.
17.

Separate functional features of proinsulin C-peptide.

Henriksson M, Nordling E, Melles E, Shafqat J, Ståhlberg M, Ekberg K, Persson B, Bergman T, Wahren J, Johansson J, Jörnvall H.

Cell Mol Life Sci. 2005 Aug;62(15):1772-8.

PMID:
16003487
18.

N-terminal segment of proinsulin C-peptide active in insulin interaction/desaggregation.

Nerelius C, Alvelius G, Jörnvall H.

Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):462-7. doi: 10.1016/j.bbrc.2010.11.058. Epub 2010 Nov 19.

PMID:
21094141
19.

New aspects on biological activity of C-peptide in IDDM patients.

Forst T, Kunt T, Pfützner A, Beyer J, Wahren J.

Exp Clin Endocrinol Diabetes. 1998;106(4):270-6. Review.

PMID:
9792458
20.

Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level.

De La Tour DD, Raccah D, Jannot MF, Coste T, Rougerie C, Vague P.

Diabetologia. 1998 Sep;41(9):1080-4.

PMID:
9754827

Supplemental Content

Support Center